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Objective: This study was undertaken to test whether risk models developed from
on-pump coronary artery bypass grafting are valid for assessing the risk for
off-pump coronary artery bypass grafting.
Methods: From January 1997 through June 2002, a total of 12,845 patients under-
went isolated coronary artery bypass grafting procedures in Providence Health
System hospitals. Of these, 1782 operations (14%) were performed without cardio-
pulmonary bypass. An operative mortality risk model was derived from on-pump
data with logistic regression. This model and two other external risk models
developed from on-pump data were then applied to patients undergoing off-pump
coronary artery bypass grafting to test the model adequacy.
Results: Good model discrimination and calibration were obtained from all three
models.
Conclusion: Operative mortality risk models developed from on-pump coronary
artery bypass grafting can be used to assess the risk for off-pump coronary artery
bypass grafting.
In a recent editorial on coronary artery bypass grafting (CABG), accompa-nying an article by Mack and colleagues1 that presented the results ofoff-pump CABG (OPCAB), Bonchek2 posed an interesting question: “Arethe risk models in the Society of Thoracic Surgeons (STS) NationalDatabase, which are derived from experience with on-pump CABG, validfor assessing risk for patients undergoing OPCAB?” We tried to find the
answer from an analysis of 5 years’ experience with 12,845 isolated CABG
surgeries in the Providence Heath System (PHS) collaborative cardiac database.
Methods
Patients
From January 1997 through June 2002, a total of 12,845 patients underwent isolated CABG
procedures in 9 PHS hospitals. Of these, 1782 operations (14%) were performed without
cardiopulmonary bypass. Table 1 compares the major features of the on-pump CABG and
OPCAB groups. All nine PHS hospitals participating in the cardiac surgery programs
collected the data according to the same definitions, and the data were merged into the PHS
collaborative cardiac database (see Appendix Table 1 for details).
Statistical Methods
To test whether risk models derived from on-pump CABG surgery are valid for assessing the
risk of OPCAB, the PHS data were split into two subsets. The patients who underwent
on-pump CABG were used as the training set for model development, and the OPCAB group
was used as the test set for model validation. An operative mortality risk model was
developed by logistic regression with the training set only. Model entry criteria were set at
P  .20, and removal criteria were set at P  .20. The resulting model was then applied to
the test set to test the model adequacy for OPCAB. Two other risk models, the Northern New
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England (NNE) risk model (unpublished model, provided by cour-
tesy of Dr Pamela Jenkins) and the logistic EuroSCORE model,3
(http://www.euroscore.org/logisticEuroSCORE.htm), both of
which were developed from on-pump surgery only, were also
applied to the patients undergoing OPCAB. We did not apply the
Society of Thoracic Surgeons (STS) CABG risk model because
not all the risk factors in STS CABG risk model were collected in
the PHS collaborative cardiac database.
For both the training and test sets, the area under the receiver
operating characteristic curve, also called the C-statistic,4 which
evaluates the ability of a model to correctly classify dead and alive,
was used to measure model discrimination. The Hosmer-Leme-
show test5 was used to measure model calibration, the agreement
between estimated and actual mortality.
Applying external risk models (eg, NNE or EuroSCORE) may
lead to overestimation or underestimation of the predicted risk,
because perfect matching of risk factors from one system to
another is unlikely. Unlike poor discrimination, however, poor
calibration can be improved by secondary logistic regression (us-
ing the original logit as an independent risk factor)6. We calibrated
the two external models so that the overall predicted operative
mortality would be equal to the observed.7 The discrimination was
unchanged by recalibration.
Results
The demographic and clinical characteristics were similar
for the on-pump and OPCAB groups (Table 1). P values are
not given because P  .05 does not necessarily mean the
difference has clinical significance, especially when the
sample sizes are large.
The risk model developed from the on-pump training set
is described in Appendix Table 2. Twelve variables were
found to be risk factors for operative death. The C-statistic
for this model was 0.810, which indicated good discrimi-
nation, and the P value for the Hosmer-Lemeshow test was
.937, which indicated good calibration. For the test set, the
C-statistic was 0.781 and the Hosmer-Lemeshow test P
value was .511, which also indicated good discrimination
and calibration, respectively. Good model discrimination
and calibration were also obtained when applying NNE and
EuroSCORE risk models to the test set (Table 2). Because
the PHS risk model derived from on-pump data works
efficiently in predicting operative death for patients under-
going OPCAB, we combined the training set and the test set
and produced a final PHS model (Appendix Table 2). We
also applied the NNE and the EuroSCORE risk models to
the entire set of patients. The C-statistic and the Hosmer-
Lemeshow test showed that all the three models performed
well (Table 2). We compared the final PHS-predicted risks
with the calibrated NNE-predicted risks (Figure 1) and the
calibrated EuroSCORE (Figure 2) for all patients undergo-
ing CABG, on and off pump, and good agreement was
found between PHS and the two external models.
Discussion
The 1996 STS CABG risk model was developed from a
cohort of patients who underwent on-pump CABG from
1990 through 1996.8 Bonchek2 asked whether the STS risk
models for on-pump CABG were valid to assess the risk of
OPCAB, because some variables unique to OPCAB that
TABLE 2. C-Statistics and Hosmer-Lemeshow test
C-statistic
Hosmer-Lemeshow
test
OPCAB
On-pump PHS 0.781 0.511
Calibrated NNE 0.827 0.708
Calibrated EuroSCORE 0.802 0.453
All CABG
Final PHS 0.806 0.376
Calibrated NNE 0.786 0.669
Calibrated EuroSCORE 0.780 0.456
TABLE 1. Clinical characteristics of on-pump CABG and
OPCAB groups
On-pump CABG OPCAB
Age (y, mean  SD) 65 11 67 11
Ejection fraction (%, mean  SD) 57 15 58 14
Body surface area (m2, mean  SD) 2.0 0.2 2.0 0.2
No. of diseased vessels (mean  SD) 2.2 0.9 2.1 1.0
Female (%) 24% 28%
Surgical urgency (%)
Elective 55% 62%
Urgent 39% 35%
Emergency 6% 3%
Salvage 0.3% 0.1%
History of cerebrovascular disease
(%)
11% 13%
History of peripheral vascular disease
(%)
15% 15%
History of renal failure (%) 4% 6%
Diabetes (%) 31% 31%
History of chronic lung disease (%) 15% 11%
Systemic hypertension (%) 30% 30%
Pulmonary hypertension (%) 3% 2%
Mitral insufficiency (%)
Mild 7% 8%
Moderate 15% 4%
Severe 0.2% 0.1%
History of congestive heart failure (%) 18% 12%
Left main stenosis 50% (%) 20% 26%
New York Heart Association functional class (%)
I 38% 52%
II 16% 10%
III 24% 23%
IV 22% 15%
Canadian Cardiovascular Society
class IV (%)
32% 31%
Preoperative intra-aortic balloon
pump (%)
4% 4%
Previous cardiac surgery (%) 8% 5%
Operative mortality (%) 2.3% 2.5%
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could affect mortality, morbidity, and the selection of pa-
tients for OPCAB were not being collected (eg, intramyo-
cardial coronary arteries, diffuse coronary disease, small
and poor-quality target vessels, aortic atherosclerosis, left
ventricular hypertrophy). With regard to mortality, we tried
to answer the question by using a simple model validation
method, data splitting. The risk model for operative mor-
tality derived from our PHS on-pump data performed well
with our OPCAB data. This was confirmed when two ex-
ternal risk models that also had been derived from on-pump
data were applied. It is true that not all the potential risk
factors are always available for selection, and no risk model
can identify all the risk factors. The PHS, NNE, and Euro-
SCORE risk models may have not considered all of the
potentially important risk factors for OPCAB (and perhaps
not even for on-pump CABG), but although none are ideal,
they all worked well in assessing the operative mortality
among patients undergoing OPCAB. Sergeant and associ-
ates9 used the EuroSCORE risk model10 to evaluate their
OPCAB experience and obtained good model discrimina-
tion. The NNE risk model used in this study was based on
on-pump data only, but the NNE Cardiovascular Disease
Study Group has recently compare the risk-adjusted mor-
tality and morbidity between on-pump CABG and OPCAB,
and all the patients undergoing CABG were used to develop
the logistic regression models11. Though the OPCAB group
was excluded from the published 1996 STS risk model, the
same set of risk factors for the STS mortality and morbidity
risk models have been used to develop the risk models for
all patients undergoing CABG; these models were thereafter
used to compare risk-adjusted mortality and morbidity be-
tween on-pump CABG and OPCAB.12
This study has some technical limitations. We have not
validated the comparability of these risk models within the
STS Database. Furthermore, our database assigned patients
to the on-pump or OPCAB groups solely on the basis of the
operation they finally underwent and did not assess the
incidence or influence of intraoperative conversion from
OPCAB to on-pump CABG. We also did not assess the
potential influence of differences in mortality among differ-
ent surgeons. As pointed out in Bonchek’s editorial,2, the
report of OPCAB results by Mack and colleagues1 revealed
marked differences in mortality among surgeons, and those
with the lowest operative mortality rates performed the vast
majority of OPCAB procedures. This phenomenon may have
influenced the observation of Cleveland and colleagues12 that
operative mortality in the STS Database was lower for OP-
CAB than for on-pump CABG. The influence of the surgeon’s
skill and experience on the on-pump versus OPCAB operative
risk for any individual patient requires further study. Subject to
these limitations, however, we conclude that risk model for
operative mortality in the PHS Database that was developed
from on-pump data can be used for assessing the risk for
patients undergoing OPCAB.
Figure 1. Scattergram of calibrated NNE predicted risk versus PHS predicted risk. Small gray dots indicate
patients alive; large black dots indicate patients dead. Horizontal and vertical axes are in logit scale. Diagonal line
is 45° line of perfect agreement. Both gray and black dots are almost equally distributed around diagonal line,
which indicates good agreement between calibrated NNE predicted risk and PHS predicted risk. Black dots get
denser as logits get larger on both risk scales, which means larger predicted risk is associated with higher
mortality.
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Figure 2. Scattergram of calibrated logistic EuroSCORE vs. Providence Health System (PHS) predicted risk. Small
gray dots indicate patients alive; large black dots indicate patients dead. Horizontal and vertical axes are in logit
scale. Diagonal line is 45° line of perfect agreement. Both gray and black dots are almost equally distributed
around diagonal line, which indicates good agreement between calibrated logistic EuroSCORE and PHS predicted
risk. Black dots get denser as logits get larger on both risk scales, which means larger predicted risk is associated
with higher mortality.
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Appendix TABLE 1. Preoperative risk factors
Risk factor Definition Codes in regression
Age Age in years (Age 60)/10
Female gender Female gender 1, Female; 0, male
Ejection fraction Last calculated ejection fraction; percent of blood
emptied from left ventricle at end of
contraction
Exact value or midpoint of range
Urgency Status at entry to operating room 0, Elective; 1, urgent; 3,
emergency; 6, salvage
History of cerebrovascular disease History of cerebrovascular disease, documented
by any of following: cerebrovascular accident,
reversible ischemic neurologic deficit, transient
ischemic attack, unresponsive coma 24 h,
noninvasive or invasive carotid test with 75%
occlusion
0, No; 1, yes
History of peripheral vascular disease Peripheral vascular disease diagnosis from
history of claudication, absent pedal pulses,
positive noninvasive test result, abnormal
arteriogram, previous vascular operations or
amputation for nontraumatic arterial
insufficiency; does not include carotid disease
0, No; 1, yes
History of renal insufficiency History of acute or chronic renal insufficiency or
dialysis, or history of creatinine 2.0 mg/dL
0, No; 1, yes
Previous cardiac surgery Previous CABG, valve replacement or repair,
aortic root replacement or reconstruction, or
congenital heart surgery
0, No; 1, yes
Left main Categorized percentage of stenosis 0, 50%; 1, 50%
New York Heart Association functional class New York Heart Association functional class of
congestive heart failure
1, Class I; 2, class II; 3, class III;
4, class IV
History of chronic lung disease Any documented history of chronic lung disease
(chronic obstructive pulmonary disease,
asthma, bronchitis) or current treatment with
pharmacologic therapy
0, No; 1, yes
Canadian Cardiovascular Society class Canadian Cardiovascular Society classification of
angina
0, Class 0-III; 1, class IV
Appendix TABLE 2. PHS CABG operative mortality risk model
Training model (on-pump patientes only) Final model (all CABG patients)
B
Odds
ratio
95% Confidence
interval B
Odds
ratio
95% Confidence
interval
Transformed age* 0.331 1.39 1.15-1.68 0.322 1.38 1.16-1.64
(Transformed age*)2 0.158 1.17 1.07-1.28 0.181 1.20 1.10-1.30
Female gender 0.259 1.30 0.97-1.72 0.278 1.32 1.02-1.72
Ejection fraction 0.024 0.98 0.97-0.99 0.021 0.98 0.97-0.99
Urgency 0.447 1.56 1.40-1.75 0.441 1.55 1.40-1.73
History of cerebrovascular disease 0.433 1.54 1.11-2.14 0.302 1.35 0.99-1.84
History of peripheral vascular disease 0.350 1.42 1.05-1.93 0.380 1.46 1.10-1.94
History of renal insufficiency 0.897 2.45 1.65-3.65 0.925 2.52 1.76-3.60
Previous cardiac surgery 1.050 2.86 2.01-4.06 0.995 2.70 1.94-3.77
Left main stenosis 50% 0.189 1.21 0.91-1.61 0.200 1.22 0.94-1.59
New York Heart Association functional class 0.148 1.16 1.03-1.30 0.155 1.17 1.05-1.30
History of chronic lung disease 0.534 1.71 1.26-2.32 0.519 1.68 1.26-2.24
Canadian Cardiovascular Society class IV 0.307 1.36 1.03-1.80 0.248 1.28 0.99-1.66
Constant 4.431 4.554
B, Coefficient.
*Transformed age, (age 60)/10.
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